QualityStocksNewsBreaks Archives - Page 870 of 1457

WednesdayNov 11, 2020 9:19 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Virtual Fall Investor Summit

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Virtual Fall Investor Summit, hosted by Investor Summit Group and taking place November 16-18, 2020. According to the update, Trxade CEO Suren Ajjarapu is scheduled to participate in one-on-one meetings throughout the event and will host a virtual presentation at 2:30 p.m. Eastern Time (11:30 p.m. Pacific Time) on Tuesday, November 17, 2020. Interested parties may visit https://ibn.fm/gf2UL to register for the event and access the live webcast and archive of the presentation. To view the full press release, visit…

TuesdayNov 10, 2020 2:40 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Completion of Strategic Merger

180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced the successful closing of its transaction with KBL Merger Corp IV. Prior to the merger’s closing, KBL Merger Corp. changed its name to 180 Life Sciences Corp., and 180 Life Sciences Corp. changed its name to 180 Life Corp., which now operates as a wholly owned subsidiary of the company. As a result of the merger, the units and rights of KBL Merger Corp. ceased trading, and the shares of its…

TuesdayNov 10, 2020 2:11 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Expands A88CBD(TM) Ingestible Line with Innovative New Product

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its lifestyle brand A88CBD(TM) will introduce new powder packs in four exciting flavors available by the end of November. “We are thrilled to announce another exciting and innovative product for our A88CBD ingestible line,” said WTER president and CEO Ricky Wright. “Recently, we have added multiple category-leading items to our portfolio of products that differentiate us from competitors. Initial feedback has been overwhelmingly positive, resulting in strong online sales. Our latest addition, the A88CBD powder packs,…

TuesdayNov 10, 2020 1:38 pm

QualityStocksNewsBreaks – Creatd Inc. (NASDAQ: CRTD) to Discuss Q3 Financials, Business Update During Webcast

Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary technology platform for creators of all types, will hold a Nov. 17 webcast. During the webcast, company officials will discuss Creatd’s third-quarter 2020 financial numbers as well as provide key updates about business updates, including an overview of CRTD’s freemium creator and paid subscription metrics. In addition, the company will host a Q&A following the discussion of the financials. Questions can be submitted via the webcast portal or emailed (ir@creatd.com) prior to the webcast. Creatd anticipates releasing the company’s financial results after the market closes on Monday, Nov. 16, 2020. The…

TuesdayNov 10, 2020 12:49 pm

QualityStocksNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) to Present at Virtual Fall Investor Summit

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that management will present at the Virtual Fall Investor Summit taking place from November 16 - 18, 2020. According to the update, Sigma Labs CEO Mark K. Ruport is scheduled to host a virtual presentation at 9:00 a.m. ET on Wednesday, November 18, 2020, and will also participate in one-on-one meetings throughout the day. Sigma’s presentation will highlight its new PrintRite3D Lite In-Process Quality Assurance system, IN4.OS Strategic Alliance for Factories of the Future and recent contract awards. Interested parties…

TuesdayNov 10, 2020 12:25 pm

QualityStocksNewsBreaks – Cannabis Strategic Ventures (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales

Cannabis Strategic Ventures (OTCQB:NUGS), an emerging leader in the U.S. cannabis marketplace, has announced its quarterly financial report for the period ending Sept. 30, 2020. A highlight of the report was the $6.4 million in sales for the period, a number that is up nearly 100% compared to the previous quarter, which totaled $3.3 million. Overall, the financial numbers indicate the company’s vigorous growth and wide-ranging expansion as it strengthens its position within the rapidly growing California cannabis marketplace. The increase in sales between the two quarters was more than 90%; the $6.4 million in sales represented a year-over-year increase…

TuesdayNov 10, 2020 11:59 am

QualityStocksNewsBreaks – The Movie Studio Inc. (MVES), VIVA Entertainment Group Inc. (OTTV) Enter Strategic Partnership, Service Agreement

The Movie Studio (OTC: MVES) today announced its entry into a strategic partnership and service agreement with VIVA Entertainment Group (OTC: OTTV) to align the mutually beneficial assets and associations of the two publicly traded companies. According to the update, the collaboration specifically focuses on potential cross advertising between the companies’ over-the-top (“OTT”) platforms and apps, content licensing, production and distribution services, as well as associations of current intellectual properties during the term of the agreement. “We are extremely excited about the strategic partnership with VIVA Entertainment, and the symbiotic approach that we both see regarding OTT platforms synchronizes with…

TuesdayNov 10, 2020 11:35 am

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Scientific Advisory Board with Strategic Appointment

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the addition of George K. Gittes, MD to its Scientific Advisory Board (“SAB”). According to the update, Dr. Gittes is the inventor of GNPX’s licensed diabetes gene therapy technology that is currently in development and serves as the chief of pediatric surgery and surgeon-in-chief emeritus at the UPMC Children’s Hospital of Pittsburgh. “We are delighted to have Dr. Gittes join our Scientific Advisory Board as Genprex continues to advance its diabetes program,” said Rodney Varner, Genprex’s president and chief…

TuesdayNov 10, 2020 11:12 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Enters LOI with Asymchem for MS1819 Development, Production

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced its entry into a binding letter of intent (“LOI”) with Asymchem, a leading global contract development and manufacturing service (“CDMO”) provider, for the development and production of MS1819 for the treatment of exocrine pancreatic insufficiency. Under the agreement, Asymchem will implement fermentation, verify protein expression and ultimately fine-tune the technology suitable for production of MS1819. Asymchem will be responsible for sourcing all materials required for the program under Current Good Manufacturing Practice (“cGMP”) regulatory conditions. “With a fairly competitive landscape for CDMOs,…

TuesdayNov 10, 2020 10:41 am

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Selected to Present at Upcoming Investor Conferences

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is slated to present at two upcoming investor conferences. Representing LexaGene at the conferences will be founder and CEO Jack Regan. Regan will be a presenter at the Investor Summit Group Conference held Nov. 18, 2020, at 1:30 p.m. and at the Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum scheduled for Nov. 19, 2020, at 10 a.m. EST; additional information about these conferences and Regan’s presentations is available on the event page of LexaGene’s website.“This is an excellent opportunity for the Company…

Site Search

Company Search

Category: QualityStocksNewsBreaks